MYC and neoplasm: Though the key modulators driving metabolic reprogramming have been addressed, such as the activations of c-Myc and HIF-1 17, 18, whether and how the metabolic-related genetic alterations contribute to tumor metastasis and aggressive phenotype generation are still largely unchartered.